KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway |
Song, In-Sung
(National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University)
Jeong, Yu Jeong (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) Nyamaa, Bayalagmaa (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) Jeong, Seung Hun (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) Kim, Hyoung Kyu (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) Kim, Nari (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) Ko, Kyung Soo (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) Rhee, Byoung Doo (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) Han, Jin (National Research Laboratory for Mitochondrial Signaling, Department of Physiology, College of Medicine, Cardiovascular and Metabolic Disease Center, Inje University) |
1 | Lonial S, Waller EK, Richardson PG et al (2005) Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma. Blood 106, 3777-3784 DOI |
2 | Song IS, Jeong YJ, Jeong SH et al (2013) Combination treatment with 2-methoxyestradiol overcomes bortezomib resistance of multiple myeloma cells. Exp Mol Med 45, e50 DOI |
3 | Kong PJ, Byun JS, Lim SY et al (2008) Melatonin Induces Akt Phosphorylation through Melatonin Receptor- and PI3K-Dependent Pathways in Primary Astrocytes. Korean J Physiol Pharmacol 12, 37-41 DOI |
4 | Xie H, Hu J, Pan H, Lou Y, Lv P, Chen Y (2014) Adenovirus vector-mediated FAM176A overexpression induces cell death in human H1299 non-small cell lung cancer cells. BMB Rep 47, 104-109 DOI |
5 | Liu SJ, Yin CX, Ding MC, Xia SY, Shen QM, Wu JD (2014) Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB. BMB Rep 47, 388-392 DOI |
6 | Tan G, Heqing L, Jiangbo C et al (2002) Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. Int J Cancer 97, 168-172 DOI |
7 | Esteve MA, Carre M and Braguer D (2007) Microtubules in apoptosis induction: are they necessary? Curr Cancer Drug Targets 7, 713-729 DOI |
8 | Staudt LM (2010) Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol 2, a000109 DOI |
9 | DiDonato JA, Mercurio F and Karin M (2012) NF-kappaB and the link between inflammation and cancer. Immunol Rev 246, 379-400 DOI |
10 | Song IS, Kim HK, Lee SR et al (2013) Mitochondrial modulation decreases the bortezomib-resistance in multiple myeloma cells. Int J Cancer 133, 1357-1368 DOI |
11 | Park J, Bae EK, Lee C et al (2014) Establishment and characterization of bortezomib-resistant U266 cell line: constitutive activation of NF-kappaB-mediated cell signals and/or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosis. BMB Rep 47, 274-279 DOI |
12 | Yi MJ, Park SH, Cho HN et al (2002) Heat-shock protein 25 (Hspb1) regulates manganese superoxide dismutase through activation of Nfkb (NF-kappaB). Radiat Res 158, 641-649 DOI |
13 | Lam LT, Davis RE, Pierce J et al (2005) Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res 11, 28-40 DOI |
14 | Richardson PG, Hideshima T, Mitsiades C and Anderson KC (2007) The emerging role of novel therapies for the treatment of relapsed myeloma. J Natl Compr Canc Netw 5, 149-162 |
15 | San Miguel J, Blade J, Boccadoro M et al (2006) A practical update on the use of bortezomib in the management of multiple myeloma. Oncologist 11, 51-61 DOI |
16 | Chauhan D, Li G, Podar K et al (2004) Targeting mitochondria to overcome conventional and bortezomib/ proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells. Blood 104, 2458-2466 DOI |
17 | Ocio EM, Mateos MV, Maiso P, Pandiella A and San- Miguel JF (2008) New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings. Lancet Oncol 9, 1157-1165 DOI |
18 | Enos AP and Morris NR (1990) Mutation of a gene that encodes a kinesin-like protein blocks nuclear division in A. nidulans. Cell 60, 1019-1027 DOI |
19 | Hanahan D and Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57-70 DOI |
20 | Vale RD and Fletterick RJ (1997) The design plan of kinesin motors. Annu Rev Cell Dev Biol 13, 745-777 DOI |
21 | Sawin KE and Mitchison TJ (1995) Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle. Proc Natl Acad Sci U S A 92, 4289-4293 DOI |
22 | Rowinsky EK, Chaudhry V, Cornblath DR and Donehower RC (1993) Neurotoxicity of Taxol. J Natl Cancer Inst Monogr, 107-115 |
23 | Talapatra SK, Anthony NG, Mackay SP and Kozielski F (2013) Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism. J Med Chem 56, 6317-6329 DOI |
24 | Yin Y, Sun H, Xu J et al (2014) Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells. Leuk Lymphoma, 1-8 |
25 | Kyle RA and Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351, 1860-1873 DOI |